Cargando…
Adverse karyotype subcategories in acute myeloid leukemia display significant differences in mutation composition and transplant-augmented survival
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827171/ https://www.ncbi.nlm.nih.gov/pubmed/36073516 http://dx.doi.org/10.3324/haematol.2022.281495 |
| _version_ | 1784867017257385984 |
|---|---|
| author | Tefferi, Ayalew Singh, Amritpal Gangat, Naseema Al-Kali, Aref Alkhateeb, Hassan Shah, Mithun Patnaik, Mrinal S. Elliott, Michelle A. Hogan, William J. Litzow, Mark R. Wolanskyj-Spinner, Alexandra Hook, Christopher C. Mangaonkar, Abhishek Viswanatha, David Chen, Dong Pardanani, Animesh Begna, Kebede H. Ketterling, Rhett P. |
| author_facet | Tefferi, Ayalew Singh, Amritpal Gangat, Naseema Al-Kali, Aref Alkhateeb, Hassan Shah, Mithun Patnaik, Mrinal S. Elliott, Michelle A. Hogan, William J. Litzow, Mark R. Wolanskyj-Spinner, Alexandra Hook, Christopher C. Mangaonkar, Abhishek Viswanatha, David Chen, Dong Pardanani, Animesh Begna, Kebede H. Ketterling, Rhett P. |
| author_sort | Tefferi, Ayalew |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9827171 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98271712023-01-20 Adverse karyotype subcategories in acute myeloid leukemia display significant differences in mutation composition and transplant-augmented survival Tefferi, Ayalew Singh, Amritpal Gangat, Naseema Al-Kali, Aref Alkhateeb, Hassan Shah, Mithun Patnaik, Mrinal S. Elliott, Michelle A. Hogan, William J. Litzow, Mark R. Wolanskyj-Spinner, Alexandra Hook, Christopher C. Mangaonkar, Abhishek Viswanatha, David Chen, Dong Pardanani, Animesh Begna, Kebede H. Ketterling, Rhett P. Haematologica Letter to the Editor Fondazione Ferrata Storti 2022-09-08 /pmc/articles/PMC9827171/ /pubmed/36073516 http://dx.doi.org/10.3324/haematol.2022.281495 Text en Copyright© 2023 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letter to the Editor Tefferi, Ayalew Singh, Amritpal Gangat, Naseema Al-Kali, Aref Alkhateeb, Hassan Shah, Mithun Patnaik, Mrinal S. Elliott, Michelle A. Hogan, William J. Litzow, Mark R. Wolanskyj-Spinner, Alexandra Hook, Christopher C. Mangaonkar, Abhishek Viswanatha, David Chen, Dong Pardanani, Animesh Begna, Kebede H. Ketterling, Rhett P. Adverse karyotype subcategories in acute myeloid leukemia display significant differences in mutation composition and transplant-augmented survival |
| title | Adverse karyotype subcategories in acute myeloid leukemia display significant differences in mutation composition and transplant-augmented survival |
| title_full | Adverse karyotype subcategories in acute myeloid leukemia display significant differences in mutation composition and transplant-augmented survival |
| title_fullStr | Adverse karyotype subcategories in acute myeloid leukemia display significant differences in mutation composition and transplant-augmented survival |
| title_full_unstemmed | Adverse karyotype subcategories in acute myeloid leukemia display significant differences in mutation composition and transplant-augmented survival |
| title_short | Adverse karyotype subcategories in acute myeloid leukemia display significant differences in mutation composition and transplant-augmented survival |
| title_sort | adverse karyotype subcategories in acute myeloid leukemia display significant differences in mutation composition and transplant-augmented survival |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827171/ https://www.ncbi.nlm.nih.gov/pubmed/36073516 http://dx.doi.org/10.3324/haematol.2022.281495 |
| work_keys_str_mv | AT tefferiayalew adversekaryotypesubcategoriesinacutemyeloidleukemiadisplaysignificantdifferencesinmutationcompositionandtransplantaugmentedsurvival AT singhamritpal adversekaryotypesubcategoriesinacutemyeloidleukemiadisplaysignificantdifferencesinmutationcompositionandtransplantaugmentedsurvival AT gangatnaseema adversekaryotypesubcategoriesinacutemyeloidleukemiadisplaysignificantdifferencesinmutationcompositionandtransplantaugmentedsurvival AT alkaliaref adversekaryotypesubcategoriesinacutemyeloidleukemiadisplaysignificantdifferencesinmutationcompositionandtransplantaugmentedsurvival AT alkhateebhassan adversekaryotypesubcategoriesinacutemyeloidleukemiadisplaysignificantdifferencesinmutationcompositionandtransplantaugmentedsurvival AT shahmithun adversekaryotypesubcategoriesinacutemyeloidleukemiadisplaysignificantdifferencesinmutationcompositionandtransplantaugmentedsurvival AT patnaikmrinals adversekaryotypesubcategoriesinacutemyeloidleukemiadisplaysignificantdifferencesinmutationcompositionandtransplantaugmentedsurvival AT elliottmichellea adversekaryotypesubcategoriesinacutemyeloidleukemiadisplaysignificantdifferencesinmutationcompositionandtransplantaugmentedsurvival AT hoganwilliamj adversekaryotypesubcategoriesinacutemyeloidleukemiadisplaysignificantdifferencesinmutationcompositionandtransplantaugmentedsurvival AT litzowmarkr adversekaryotypesubcategoriesinacutemyeloidleukemiadisplaysignificantdifferencesinmutationcompositionandtransplantaugmentedsurvival AT wolanskyjspinneralexandra adversekaryotypesubcategoriesinacutemyeloidleukemiadisplaysignificantdifferencesinmutationcompositionandtransplantaugmentedsurvival AT hookchristopherc adversekaryotypesubcategoriesinacutemyeloidleukemiadisplaysignificantdifferencesinmutationcompositionandtransplantaugmentedsurvival AT mangaonkarabhishek adversekaryotypesubcategoriesinacutemyeloidleukemiadisplaysignificantdifferencesinmutationcompositionandtransplantaugmentedsurvival AT viswanathadavid adversekaryotypesubcategoriesinacutemyeloidleukemiadisplaysignificantdifferencesinmutationcompositionandtransplantaugmentedsurvival AT chendong adversekaryotypesubcategoriesinacutemyeloidleukemiadisplaysignificantdifferencesinmutationcompositionandtransplantaugmentedsurvival AT pardananianimesh adversekaryotypesubcategoriesinacutemyeloidleukemiadisplaysignificantdifferencesinmutationcompositionandtransplantaugmentedsurvival AT begnakebedeh adversekaryotypesubcategoriesinacutemyeloidleukemiadisplaysignificantdifferencesinmutationcompositionandtransplantaugmentedsurvival AT ketterlingrhettp adversekaryotypesubcategoriesinacutemyeloidleukemiadisplaysignificantdifferencesinmutationcompositionandtransplantaugmentedsurvival |